GB0205395D0 - Materials and methods relating to the treatment of lymphoma - Google Patents
Materials and methods relating to the treatment of lymphomaInfo
- Publication number
- GB0205395D0 GB0205395D0 GB0205395A GB0205395A GB0205395D0 GB 0205395 D0 GB0205395 D0 GB 0205395D0 GB 0205395 A GB0205395 A GB 0205395A GB 0205395 A GB0205395 A GB 0205395A GB 0205395 D0 GB0205395 D0 GB 0205395D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- lymphoma
- treatment
- materials
- methods relating
- relating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0205395A GB0205395D0 (en) | 2002-03-07 | 2002-03-07 | Materials and methods relating to the treatment of lymphoma |
PCT/GB2003/000783 WO2003074059A2 (en) | 2002-03-07 | 2003-02-24 | Materials and methods relating to the treatment of lymphoma |
AU2003215725A AU2003215725A1 (en) | 2002-03-07 | 2003-02-24 | Materials and methods relating to the treatment of lymphoma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0205395A GB0205395D0 (en) | 2002-03-07 | 2002-03-07 | Materials and methods relating to the treatment of lymphoma |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0205395D0 true GB0205395D0 (en) | 2002-04-24 |
Family
ID=9932517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0205395A Ceased GB0205395D0 (en) | 2002-03-07 | 2002-03-07 | Materials and methods relating to the treatment of lymphoma |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003215725A1 (en) |
GB (1) | GB0205395D0 (en) |
WO (1) | WO2003074059A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006100582A1 (en) * | 2005-03-25 | 2006-09-28 | Glycart Biotechnology Ag | Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function |
WO2008053486A1 (en) * | 2006-11-02 | 2008-05-08 | Sylvie Luria | Methods for screening for therapeutic molecules and use of the molecules therefrom |
US10159675B2 (en) * | 2015-12-02 | 2018-12-25 | Celgene Corporation | Cycling therapy using 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione |
-
2002
- 2002-03-07 GB GB0205395A patent/GB0205395D0/en not_active Ceased
-
2003
- 2003-02-24 WO PCT/GB2003/000783 patent/WO2003074059A2/en not_active Application Discontinuation
- 2003-02-24 AU AU2003215725A patent/AU2003215725A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003074059A3 (en) | 2004-01-08 |
AU2003215725A1 (en) | 2003-09-16 |
WO2003074059A2 (en) | 2003-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003224638A8 (en) | Pdpk1s as modifiers of the p53 pathway and methods of use | |
EP1546112A4 (en) | Imidazolopyridines and methods of making and using the same | |
AU2003217870A8 (en) | Pini-modulating compounds and methods of use thereof | |
AU2003213673A8 (en) | Pin1-modulating compounds and methods of use thereof | |
EP1476150A4 (en) | Carboxyfullerenes and methods of use thereof | |
AU2003212634A8 (en) | Compounds useful in the treatment of cancer | |
GB0213869D0 (en) | The treatment of pain | |
GB0615918D0 (en) | Composition and its therapeutic use | |
AU2003274963A8 (en) | Mda-7 and free radicals in the treatment of cancer | |
EP1575497A4 (en) | Novel composition and methods for the treatment of psoriasis | |
GB2389645B (en) | Improvements in or relating to the treatment of molten materials | |
EP1545287A4 (en) | Vasoregulating compounds and methods of their use | |
GB0205395D0 (en) | Materials and methods relating to the treatment of lymphoma | |
IL164951A0 (en) | The treatment of pain with lfendropil | |
AU2003272390A8 (en) | Ampds as modifiers of the p21 pathway and methods of use | |
GB2392839A8 (en) | Use of Mycobacterium w in the treatment of tubercolosis | |
AU2003244437A1 (en) | Quinoxalinones and their use especially in the treatment of cardiovascular diseases | |
AU2003303094A8 (en) | Mat2as as modifiers of the p53 pathway and methods of use | |
AU2003251826A8 (en) | Mp21s as modifiers of the p21 pathway and methods of use | |
EP1534852A4 (en) | CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
GB0329357D0 (en) | Treatment of materials | |
GB0218926D0 (en) | Improvements in and relating to the treatment of sunburn | |
AU2003263993A8 (en) | Mp2153s as modifiers of the p21 or p53 pathway and methods of use | |
AU2003293714A1 (en) | Methods for the treatment of chronic pain and compositions therefor | |
GB0318890D0 (en) | Improvements in and relating to the treatment of sunburn |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |